In...
Category: neurology
7May 2012
In a thoughtful post Friday, Gary Stix at Scientific American reported on a study of six British newspapers by researchers at University College of London. The study found that “research was being applied out of context to create dramatic headlines, push thinly disguised ideological arguments, or support particular policy agendas.”
We might be hard put to find any area of science coverage that hasn't been subject to those kinds of distortions. Coverage of Lipitor and its ilk was certainly as likely to contain dramatic...
Last week, Gary Schwitzer's excellent...
Last week, Gary Schwitzer's excellent Health News Review gave a moderately favorable three-out-of-five stars to a story by HealthDay on a case report of a single patient whose blood pressure was lowered by deep brain stimulation.
Schwitzer's panel of experts rated the story satisfactory on several grounds, while criticizing it for not being clear enough on the potential harms and benefits of the technique, in which a probe is inserted deep into the brain to deliver an...
It's an old story: A generic drug looks promising, but because anybody can make it, nobody wants to.
Drug companies, unlike many other businesses, often refuse to sell a product unless they have monopoly control. I guess we should be grateful they still sell us aspirin.
As I say, it's an old story....
It's an old story: A generic drug looks promising, but because anybody can make it, nobody wants to.
Drug companies, unlike many other businesses, often refuse to sell a product unless they have monopoly control. I guess we should be grateful they still sell us aspirin.
As I say, it's an old story. But Marie McCullough of the Philadelphia Inquirer has made this story fresh again with a nice piece on a generic multiple sclerosis drug that looks promising but is still years and millions of dollars away from approval.
She begins with that old standby, the anecdotal lede--but it's a good one. It's about a woman who has...
©2010 Knight Science Journalism at MIT. All Rights Reserved.